MyAverix Finance
US · Healthcare
Valion Bio Inc (VBIO)
Biotechnology
Valion Bio Inc (VBIO) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-19, reported market cap is $2.76M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for VBIO
Valion Bio Inc (VBIO) — FAQ
What is Valion Bio Inc's market cap?
Valion Bio Inc (VBIO) has a reported market cap of $2.76M (data as of 2026-05-19).
What is VBIO's P/E ratio?
The price-to-earnings (P/E) ratio for Valion Bio Inc (VBIO) is 18.00 (data as of 2026-05-19).
Does Valion Bio Inc pay a dividend?
Dividend yield is not available in the current snapshot for Valion Bio Inc (VBIO). Check the MyAverix Finance app for the latest dividend data.
What sector is Valion Bio Inc in?
Valion Bio Inc (VBIO) is classified in the Healthcare sector (Biotechnology industry).
What exchange is VBIO listed on?
VBIO is listed on US.
What is Valion Bio Inc's net margin?
Valion Bio Inc (VBIO) reports a net margin of 0.0% (data as of 2026-05-19).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.